However, FBXO5 was negatively regulated by PLK1, which was associated with important clinicopathological characteristics, and FBXO5 siRNA promoted bladder cancer cell proliferation, invasion and migration. This evidence concerns the gene PLK1 and urinary bladder carcinoma.